Citrate Anticoagulation in Dialysis for Liver and Kidney Failure
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial looks at whether a blood thinner called citrate is safe and effective in patients who have both kidney and liver failure while on continuous dialysis in the ICU. It may help guide treatment for people with serious organ problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit (ICU).
- You have acute kidney injury and need a special type of dialysis called continuous renal replacement therapy (CRRT).
- You have liver failure or significant liver problems (such as high liver enzymes or high bilirubin).
- You have shock that requires a strong blood pressure medicine (norepinephrine) or a second medicine for blood pressure.
- You are 18 years or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to give a blood thinner during dialysis to people whose bodies cannot break it down normally. It aims to make dialysis safer and more comfortable for people with kidney and liver problems.
This study tests a special blood-filtering treatment for patients in the intensive care unit (ICU) with acute kidney injury. It uses a medicine called citrate to prevent blood clotting during dialysis, which may be safer for patients whose liver cannot process citrate normally.
This trial compares the usual dose of continuous dialysis with a lower dose to see if a lower dose is just as safe and effective for critically ill patients with sudden kidney failure.
This study compares two types of dialysis fluid (citrate-based vs acetate-based) to see which better helps protect blood pressure during intermittent dialysis. It may help people in intensive care who are at risk of dialysis-related low blood pressure.
This study tests whether a specific blood-thinning method using citrate works safely and effectively in critically ill patients whose kidneys have suddenly stopped working and need a special filtering machine. Researchers want to confirm that this approach prevents dangerous blood clots while keeping patients safe.
This study compares different patterns of continuous kidney dialysis (called CRRT) to see how they affect calcium levels in the blood when using a citrate-based blood thinner. It may help find the safest way to manage calcium during treatment.
Hear when a new Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.